The most common multi-morbid conditions include coronary artery disease, atrial fibrillation, congestive heart failure, skeletal muscle wasting, metabolic syndromes including diabetes mellitus, osteoporosis, depression, anxiety, gastro-esophageal reflux disease (GERD) and lung cancer [3]
Some experience mouth sensitivity
According to his brother, "He's got no history of depression and was never the sort of person you would see feeling sorry for himself." November 20, 2007 - The FDA announces that it "has received reports of suicidal thoughts and aggressive and erratic behavior in patients who have taken Chantix." It reports that "preliminary assessment reveals that many of the cases reflect new-onset of depressed mood, suicidal ideation, and changes in emotion and behavior within days to weeks of initiating Chantix treatment" and that as soon as its "analysis is completed, FDA will communicate its conclusions and recommendations to the public." My question regarding the FDA's 11/20/07 announcement is who actually wrote it, the FDA or Pfizer, and whose interests are being protected, Pfizer's or the consumer's
Malignant Transformation in 1458 Patients with Potentially Malignant Oral Mucosal Disorders: A Follow-Up Study Based in a Taiwanese Hospital